HRMY
Harmony Biosciences Holdings, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website armonybiosciences.com
- Employees(FY) 200
- ISIN US4131971040
Performance
-4.2%
1W
-4.95%
1M
+2.01%
3M
+4.69%
6M
+2.32%
YTD
+32.57%
1Y
Profile
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. It offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.
Technical Analysis of HRMY 2024-11-04
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-11-01 11:14
- 2024-11-01 09:40
- 2024-10-31 11:40
- 2024-10-31 08:28
- 2024-10-30 22:30
- 2024-10-30 10:30
- 2024-10-30 05:04
- 2024-10-30 03:06
- 2024-10-30 02:26
Q3 2024 Harmony Biosciences Holdings Inc Earnings Call(Thomson Reuters StreetEvents)
- 2024-10-29 18:00
- 2024-10-29 17:15
- 2024-10-29 16:00
- 2024-10-29 08:40
- 2024-10-29 08:09
- 2024-10-29 07:30
- 2024-10-29 05:15
- 2024-10-28 21:27
- 2024-10-28 19:30
- 2024-10-23 10:02
- 2024-10-22 10:01
- 2024-10-16 08:05
- 2024-10-15 20:05
- 2024-10-14 09:51
- 2024-10-11 12:14
- 2024-10-09 17:02
- 2024-10-08 20:00
HRMY: Lowering target price to $36.00(Argus Research)
- 2024-10-03 11:11
Mizuho adds 2 new stocks to its Top Picks list(Investing.com)
- 2024-10-01 08:45
- 2024-09-30 20:45
- 2024-09-29 04:43
Page 1 of 9
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment.